These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12963165)

  • 1. The Million Women Study and breast cancer.
    Speroff L
    Maturitas; 2003 Sep; 46(1):1-6. PubMed ID: 12963165
    [No Abstract]   [Full Text] [Related]  

  • 2. The Million Women Study--is it believable?
    Farmer R
    Climacteric; 2005 Sep; 8(3):210-3. PubMed ID: 16390752
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
    Lyytinen H; Ylikorkala O
    Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
    Biglia N; Maffei S; Lello S; Nappi RE
    Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The million women study: a critique.
    Whitehead M; Farmer R
    Endocrine; 2004 Aug; 24(3):187-93. PubMed ID: 15542884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 7. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
    J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
    [No Abstract]   [Full Text] [Related]  

  • 11. Does estrogen replacement therapy reduce the risk of fatal breast cancer in postmenopausal women?
    Willis DB
    Maturitas; 1997 Jun; 27(2):105-8. PubMed ID: 9255744
    [No Abstract]   [Full Text] [Related]  

  • 12. Tibolone in older postmenopausal women.
    Chlebowski RT; Prentice R
    N Engl J Med; 2008 Nov; 359(20):2172-3; author reply 2173. PubMed ID: 19005202
    [No Abstract]   [Full Text] [Related]  

  • 13. Some comments on the Million Women Study.
    Neves-E-Castro M
    Climacteric; 2003 Dec; 6(4):357. PubMed ID: 15006258
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and breast cancer: a clinician's message for patients.
    Speroff L
    Endocrine; 2004 Aug; 24(3):211-6. PubMed ID: 15542887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the Women's Health Initiative on clinical practice.
    Speroff L
    J Soc Gynecol Investig; 2002; 9(5):251-3. PubMed ID: 12383908
    [No Abstract]   [Full Text] [Related]  

  • 17. HRT and breast cancer: recent findings in the context of the evidence to date.
    Banks E; Canfell K; Reeves G
    Womens Health (Lond); 2008 Sep; 4(5):427-31. PubMed ID: 19072480
    [No Abstract]   [Full Text] [Related]  

  • 18. More controversy over breast cancer rates in the USA.
    Brown S
    Menopause Int; 2007 Jun; 13(2):51-2. PubMed ID: 17802647
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer.
    Dimitrakakis C; Keramopoulos D; Vourli G; Gaki V; Bredakis N; Keramopoulos A
    Climacteric; 2005 Dec; 8(4):342-51. PubMed ID: 16390769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Women's Health Initiative study: perspectives and implications for clinical practice.
    Hammond CB
    Rev Endocr Metab Disord; 2005 May; 6(2):93-9. PubMed ID: 15843880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.